Metraipolis › archive › dc_98818554ea7b

Development of Purine and Pyrrolopyrimidine Scaffolds as Potent, Selective, and Brain Penetrant NUAK1 Inhibitors — Europe PMC PMID:41257021

Source
Europe PMC (en)
Original
https://europepmc.org/article/MED/41257021
DOI
10.1021/acsmedchemlett.5c00467
License (as archived)
solo-consultazione
Archived
2026-11-10T01:09:10.280Z
SHA-256 of the archived text
314f2682a2eedfd28d3e945cb2ab8a90d62349a192cf7bbba63258248760232f
Stable URL of this page
https://metraipolis.com/documento/dc_98818554ea7b

How to cite

Development of Purine and Pyrrolopyrimidine Scaffolds as Potent, Selective, and Brain Penetrant NUAK1 Inhibitors — Europe PMC PMID:41257021 — Europe PMC (en), https://europepmc.org/article/MED/41257021 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_98818554ea7b (Metraipolis archive dc_98818554ea7b, sha256 314f2682a2eedfd28d3e945cb2ab8a90d62349a192cf7bbba63258248760232f)
BibTeX
@misc{dc98818554ea7b,
  title = {Development of Purine and Pyrrolopyrimidine Scaffolds as Potent, Selective, and Brain Penetrant NUAK1 Inhibitors — Europe PMC PMID:41257021},
  howpublished = {Europe PMC (en)},
  url = {https://europepmc.org/article/MED/41257021},
  note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_98818554ea7b; sha256 314f2682a2eedfd28d3e945cb2ab8a90d62349a192cf7bbba63258248760232f},
  year = {2026}
}

Archived text

The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/41257021. Agents can read the archived copy with the MCP tool read_document.